Total planned funding: $279,238,575
Allocations
Countries/Regions
| Eswatini | $279,238,575 |
Organizational Types
| Private Contractor | $72,233,567 |
| University | $61,254,249 |
| NGO | $48,687,196 |
| Unknown | $37,103,560 |
| Own Agency | $35,238,857 |
| Host Country Government Agency | $9,496,514 |
| FBO | $6,984,196 |
| Multi-lateral Agency | $6,638,202 |
| Other USG Agency | $842,634 |
| Implementing Agency | $759,600 |
Program Areas
| Care | $86,083,868 |
| Treatment | $65,334,236 |
| Prevention | $51,660,429 |
| Governance and Systems | $32,655,013 |
| Testing | $22,049,553 |
| Management and Operations | $21,455,476 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $49,557,897 |
| HBHC: Care: Adult Care and Support | $38,589,742 |
| HKID: Care: Orphans and Vulnerable Children | $26,445,053 |
| HVCT: Testing: HIV Testing and Counseling | $22,049,553 |
| HVMS: Management and Operations | $21,455,476 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $20,691,036 |
| HVTB: Care: TB/HIV | $14,405,260 |
| OHSS: Health Systems Strengthening | $14,174,396 |
| HVSI: Strategic Information | $13,541,881 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $11,327,350 |
| HTXD: Treatment: ARV Drugs | $10,351,636 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,168,228 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,497,029 |
| PDCS: Care: Pediatric Care and Support | $6,643,813 |
| PDTX: Treatment: Pediatric Treatment | $5,424,703 |
| HLAB: Laboratory Infrastructure | $4,938,736 |
| HMBL: Biomedical Prevention: Blood Safety | $1,976,786 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$52,214,820
Countries/Regions
Not Available:
$32,704,574
Countries/Regions
Pact, Inc.:
$32,613,442
Countries/Regions
USG Aggregated Agencies:
$21,590,105
Countries/Regions